You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

96 search results for: symptoms

expert video

The Implications of Sweat Duct Dysfunction and the Microbial Dysbiosis in AD

3 min

Dermatology

Dr. Lisa Beck talks about sweat duct dysfunction and the impact of S. aureus colonization.

expert video

Food Bolus Impaction: An Opportunity to Diagnose EoE

1 min

Gastroenterology

Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.

expert video

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases

10 min

Type 2 Inflammation

Prof. Oscar Palomares discusses the underlying pathophysiology of type 2 inflammation in pediatric patients with AD, asthma, or EoE.

Explore the clinical presentations of bullous pemphigoid (BP), the steps for diagnosis, and the burden of disease.

Infographic

Bullous Pemphigoid (BP): Don't Miss the Diagnosis

10 min

Dermatology

This static infographic covers the clinical presentations, diagnostic challenges, and disease burden of bullous pemphigoid (BP), a chronic relapsing autoimmune skin disease. Review the steps of diagnosis, which include clinical assessment and laboratory work. Explore comorbidities associated with BP and how they impact patient quality of life.

expert video

What Drives PN Disease? Exploring the Complexity of PN Pathophysiology

15 min

Dermatology

Dr. Brian Kim discusses the numerous contributors to PN pathophysiology, including type 2 inflammation, neuronal dysfunction, and dermal fibrosis, emphasizing the unique and overlapping roles of IL 31, IL-4 and IL-13 in its pathology.

expert video

The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis

1 min

Dermatology

Dr. Stephan Weidinger talks about the role of biomarkers and their impact on clinical decision-making.

expert video

How Can We Explore the Concept of Disease Modification in Children With AD?

2 min

Dermatology

Dr. Lawrence Eichenfield discusses the concept of disease modification in children with AD.

interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

5 min

Pulmonology

Learn about the disease burden and heterogeneity of COPD.

expert video

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

1 min

Gastroenterology

Dr. Jonathan Spergel and Prof. Arjan Bredenoord highlight the importance of different immune cells in type 2 inflammation in EoE.

expert video

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE

2 min

Gastroenterology

Learn from Prof. Seema Aceves about the interconnectivity of type 2 inflammation and barrier dysfunction in mediating EoE pathophysiology.

expert video

Overview of EoE Pathophysiology and the Impact on Patient Burden

4 min

Gastroenterology

Chapter from Interdisciplinary Care of Patients with EoE: Experts Offer Food for Thought video: Focuses on the pathophysiology and burden of EoE

Podcast

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

12 min

Gastroenterology

Hear Dr. Wechsler and Prof. Bredenoord discuss the multifaceted burden of EoE and how to overcome challenges in identifying EoE in clinical practice.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region